Cargando…

Cognitive Changes and Promotion in Parkinson's Disease

Detalles Bibliográficos
Autores principales:	Wang, XiaoPing, Wang, XiJin, Chen, HaiBo, Canning, Sarah Duff, Luo, Xingguang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6092979/ https://www.ncbi.nlm.nih.gov/pubmed/30155240 http://dx.doi.org/10.1155/2018/9872183

Ejemplares similares

Freezing of Gait in Parkinsonism and its Potential Drug Treatment
por: Zhang, Li-Li, et al.
Publicado: (2016)

Pharmacological and Non-pharmacological Treatments of Sleep Disorders in Parkinson's Disease
por: Taximaimaiti, Reyisha, et al.
Publicado: (2021)

Roles of Education and IQ in Cognitive Reserve in Parkinson's Disease-Mild Cognitive Impairment
por: Armstrong, M.J., et al.
Publicado: (2012)

An Update on Nondopaminergic Treatments for Motor and Non-motor Symptoms of Parkinson’s Disease
por: Jing, Xiao-Zhong, et al.
Publicado: (2023)

Currently Clinical Views on Genetics of Wilson's Disease
por: Chen, Chen, et al.
Publicado: (2015)

Multiple Evidences for Association between Cognitive Impairment and Dysglycemia in Parkinson’s Disease: Implications for Clinical Practice
por: Yang, Liu, et al.
Publicado: (2017)

Brain tissue pulsatility is related to clinical features of Parkinson's disease
por: Shirzadi, Zahra, et al.
Publicado: (2018)

Longitudinal cognitive changes in patients with early Parkinson's disease and neuropsychiatric symptoms
por: Meng, Detao, et al.
Publicado: (2023)

Efforts of subthalamic nucleus deep brain stimulation on cognitive spectrum: From explicit to implicit changes in the patients with Parkinson's disease for 1 year
por: You, ZhiFei, et al.
Publicado: (2020)

Familial Parkinson's Disease/Parkinsonism
por: Tomiyama, Hiroyuki, et al.
Publicado: (2015)

Hoist the sails, promote the hopes
por: Qiu, Li-Ru, et al.
Publicado: (2021)

Towards a Deeper Comprehension of Relationships among Cognitive, Behavioral and Psychiatric Symptoms in Parkinson’s Disease
por: Trojano, Luigi, et al.
Publicado: (2013)

Does Prefrontal Glutamate Index Cognitive Changes in Parkinson’s Disease?
por: Buard, Isabelle, et al.
Publicado: (2022)

People with Parkinson’s as Partners for the Journal of Parkinson’s Disease
por: McFarthing, Kevin, et al.
Publicado: (2023)

Behavioural and Cognitive Changes in Neurodegenerative Diseases and Brain Injury
por: Trojsi, Francesca, et al.
Publicado: (2018)

Neuroanatomical changes in Parkinson's disease in relation to cognition: An update
por: Prakash, K. G., et al.
Publicado: (2016)

Can Olfactory Tests Help to Diagnose Parkinson Disease?
por: Kim, Jin Kook
Publicado: (2019)

Substantia nigra Smad3 signaling deficiency: relevance to aging and Parkinson’s disease and roles of microglia, proinflammatory factors, and MAPK
por: Liu, Ying, et al.
Publicado: (2020)

Rehabilitation and Parkinson's Disease
por: Earhart, Gammon M., et al.
Publicado: (2012)

Neuropsychiatry of Parkinson's Disease
por: Teixeira, Antonio L., et al.
Publicado: (2012)

Inflammation and Parkinson's Disease
por: Barcia, Carlos, et al.
Publicado: (2011)

Mitochondria and Parkinson's Disease
por: Simon, David K., et al.
Publicado: (2011)

Cannabidiol in Parkinson’s disease
por: Rieder, Carlos R.
Publicado: (2020)

Gait in Parkinson's Disease
por: Martinez-Ramirez, Daniel, et al.
Publicado: (2019)

Neurobiology of Parkinson’s Disease
por: Morelli, Micaela, et al.
Publicado: (2023)

Recurrent Falls in Parkinson's Disease: A Systematic Review
por: Allen, Natalie E., et al.
Publicado: (2013)

Variation in complement protein C1q is not a major contributor to cognitive impairment in Parkinson’s disease
por: Carbutt, Sophia, et al.
Publicado: (2015)

CSF neurochemical profile and cognitive changes in Parkinson’s disease with mild cognitive impairment
por: Paolini Paoletti, Federico, et al.
Publicado: (2023)

Epidemiology of Parkinsonism and Parkinson's disease in Sub-Saharan Africa: Nigerian profile
por: Akinyemi, Rufus O
Publicado: (2012)

Lacunes may worsen cognition but not motor function in Parkinson's disease
por: Chen, Keke, et al.
Publicado: (2022)

The Rationale for Exercise in the Management of Pain in Parkinson’s Disease
por: Allen, Natalie E., et al.
Publicado: (2015)

White matter changes in Parkinson’s disease
por: Yang, Kai, et al.
Publicado: (2023)

Is There (Will There Be) a Post-COVID-19 Chronic Cough?
por: Dicpinigaitis, Peter V., et al.
Publicado: (2020)

The structural changes of gray matter in Parkinson disease patients with mild cognitive impairments
por: Li, Lihua, et al.
Publicado: (2022)

KTN1 Variants Underlying Putamen Gray Matter Volumes and Parkinson’s Disease
por: Mao, Qiao, et al.
Publicado: (2020)

White-Matter Changes Correlate with Cognitive Functioning in Parkinson’s Disease
por: Theilmann, Rebecca J., et al.
Publicado: (2013)

Grey Matter Changes in Cognitively Impaired Parkinson's Disease Patients
por: Rektorova, Irena, et al.
Publicado: (2014)

Gray Matter Changes in Parkinson’s and Alzheimer’s Disease and Relation to Cognition
por: Krajcovicova, Lenka, et al.
Publicado: (2019)

Nonmotor Symptoms of Parkinson's Disease
por: Rektorova, Irena, et al.
Publicado: (2011)

Communication Impairments in Parkinson's Disease
por: Murdoch, Bruce, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_1r6trcukkbpf1qcn8fe5n1i2jv